Aimovig offers more sustained relief, making it better for chronic conditions. Its effects last longer, making it the better choice for long-term treatment.

Both Tyblume and Aimovig have similar safety profiles, with mild and transient side effects. Neither presents significant long-term safety concerns.

Both Tyblume and Aimovig have a low risk of addiction when used correctly under medical supervision, with minimal potential for misuse.

Both Tyblume and Aimovig are easy to use, with straightforward dosing regimens that ensure good adherence.

Aimovig is better for patients with cardiovascular or diabetes-related issues, as it has fewer interactions with other medications.

Both drugs offer advantages depending on treatment goals. Tyblume is great for fast relief, while Aimovig is better for long-term management. The choice depends on the patient’s specific needs.